A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study

A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study

Abstract Background 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) of these patients. Methods de novo MBC patients diagnosed in 2010–2016 were identified from the Surveillance,...

Full description

Bibliographic Details
Main Authors: Wen Zhao, Lei Wu, Andi Zhao, Mi Zhang, Qi Tian, Yanwei Shen, Fan Wang, Biyuan Wang, Le Wang, Ling Chen, Xiaoai Zhao, Danfeng Dong, Lingxiao Zhang, Jin Yang
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Cancer
Subjects:
De novo metastatic breast cancer
Primary tumor resection
Overall survival
SEER
Nomogram
Online Access:http://link.springer.com/article/10.1186/s12885-020-07449-1

Internet

http://link.springer.com/article/10.1186/s12885-020-07449-1

Similar Items